359 related articles for article (PubMed ID: 34142285)
1. Metformin: review of epidemiology and mechanisms of action in pancreatic cancer.
Eibl G; Rozengurt E
Cancer Metastasis Rev; 2021 Sep; 40(3):865-878. PubMed ID: 34142285
[TBL] [Abstract][Full Text] [Related]
2. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
[TBL] [Abstract][Full Text] [Related]
3. Metformin as an Adjunctive Therapy for Pancreatic Cancer: A Review of the Literature on Its Potential Therapeutic Use.
Broadhurst PJ; Hart AR
Dig Dis Sci; 2018 Nov; 63(11):2840-2852. PubMed ID: 30159732
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between insulin/insulin-like growth factor-1 receptors and G protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer.
Rozengurt E; Sinnett-Smith J; Kisfalvi K
Clin Cancer Res; 2010 May; 16(9):2505-11. PubMed ID: 20388847
[TBL] [Abstract][Full Text] [Related]
5. Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Zhou G; Yu J; Wang A; Liu SH; Sinnett-Smith J; Wu J; Sanchez R; Nemunaitis J; Ricordi C; Rozengurt E; Brunicardi FC
Curr Mol Med; 2016; 16(1):83-90. PubMed ID: 26695692
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
[TBL] [Abstract][Full Text] [Related]
7. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
8. Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth.
Kisfalvi K; Eibl G; Sinnett-Smith J; Rozengurt E
Cancer Res; 2009 Aug; 69(16):6539-45. PubMed ID: 19679549
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets of metformin antitumor action.
Sośnicki S; Kapral M; Węglarz L
Pharmacol Rep; 2016 Oct; 68(5):918-25. PubMed ID: 27362768
[TBL] [Abstract][Full Text] [Related]
10. Metformin and pancreatic cancer: a clue requiring investigation.
Pollak M
Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic therapies affect risk of pancreatic cancer.
Li D; Yeung SC; Hassan MM; Konopleva M; Abbruzzese JL
Gastroenterology; 2009 Aug; 137(2):482-8. PubMed ID: 19375425
[TBL] [Abstract][Full Text] [Related]
12. Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages.
Incio J; Suboj P; Chin SM; Vardam-Kaur T; Liu H; Hato T; Babykutty S; Chen I; Deshpande V; Jain RK; Fukumura D
PLoS One; 2015; 10(12):e0141392. PubMed ID: 26641266
[TBL] [Abstract][Full Text] [Related]
13. The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.
Thakur S; Daley B; Klubo-Gwiezdzinska J
J Mol Endocrinol; 2019 Aug; 63(2):R17-R35. PubMed ID: 31307011
[TBL] [Abstract][Full Text] [Related]
14. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.
Gong J; Kelekar G; Shen J; Shen J; Kaur S; Mita M
Target Oncol; 2016 Aug; 11(4):447-67. PubMed ID: 26864078
[TBL] [Abstract][Full Text] [Related]
15. The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer.
Amin S; Boffetta P; Lucas AL
Gut Liver; 2016 Sep; 10(5):665-71. PubMed ID: 27563018
[TBL] [Abstract][Full Text] [Related]
16. Association between pancreatic cancer and metformin use in patients with type 2 diabetes.
Lai SW; Tsai CH; Lin CL; Liao KF
Postgrad Med J; 2019 May; 95(1123):291. PubMed ID: 30975725
[No Abstract] [Full Text] [Related]
17. Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies.
Lonardo E; Cioffi M; Sancho P; Crusz S; Heeschen C
J Vis Exp; 2015 Jun; (100):e52801. PubMed ID: 26132091
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and metformin in pancreatic adenocarcinoma and neuroendocrine tumors.
Burney S; Khawaja KI; Saif MW; Masud F
JOP; 2014 Jul; 15(4):313-6. PubMed ID: 25076330
[TBL] [Abstract][Full Text] [Related]
19. Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts.
Lipner MB; Marayati R; Deng Y; Wang X; Raftery L; O'Neil BH; Yeh JJ
PLoS One; 2016; 11(1):e0147113. PubMed ID: 26760500
[TBL] [Abstract][Full Text] [Related]
20. Metformin use is associated with better survival of diabetic patients with pancreatic cancer.
Sadeghi N; Abbruzzese JL; Yeung SC; Hassan M; Li D
Clin Cancer Res; 2012 May; 18(10):2905-12. PubMed ID: 22465831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]